Status:
COMPLETED
Psychobiology in Inflammatory Bowel Disease(IBD)
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University Hospital, Aker
Haukeland University Hospital
Conditions:
Inflammatory Bowel Disease
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Patients with ulcerous colitis and Crohn's disease, age 18-60, with a relapse within the last 18 months and an activity index ≥4, with a long time stress level ≥60 on the perceived stress questionnair...
Detailed Description
The study includes distressed patients with ulcerous colitis and Crohn's disease with relapse or enduring activity last 18 months and an simple activity index ≥4, on stable medication last 4 weeks. Al...
Eligibility Criteria
Inclusion
- Ulcerous colitis and Crohn's disease verified by histology and endoscope Relapse last 18 months or enduring activity Activity index≥4 PSQ≥60
Exclusion
Key Trial Info
Start Date :
February 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00248742
Start Date
February 1 2001
End Date
December 1 2006
Last Update
July 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RRHF
Oslo, Norway, 0027